Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
Tóm tắt
Từ khóa
Tài liệu tham khảo
Raman, 2011, Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005, BJU Int, 107, 1059, 10.1111/j.1464-410X.2010.09675.x
Rouprêt, 2011, European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update, Eur Urol, 59, 584, 10.1016/j.eururo.2010.12.042
NCCN guidelines. Clinical guidelines in oncology. Bladder cancer, version 2.2012. National Comprehensive Cancer Network Web site. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Chromecki, 2011, Prognostic factors for upper urinary tract urothelial carcinoma, Nat Rev Urol, 8, 440, 10.1038/nrurol.2011.96
Fernandez, 2009, Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study, Urology, 73, 142, 10.1016/j.urology.2008.07.042
Shariat, 2011, Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma, World J Urol, 29, 457, 10.1007/s00345-010-0594-7
Lughezzani, 2010, Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database, Urology, 75, 321, 10.1016/j.urology.2009.09.048
Lughezzani, 2009, Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients, Eur J Cancer, 45, 3291, 10.1016/j.ejca.2009.06.016
Shariat, 2010, Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy, BJU Int, 105, 1672, 10.1111/j.1464-410X.2009.09072.x
Chromecki, 2011, Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy, World J Urol, 29, 473, 10.1007/s00345-011-0677-0
Matsumoto, 2011, Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study, BJU Int, 108, 304, 10.1111/j.1464-410X.2011.10188.x
Martinez-Salamanca, 2012, Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study, BJU Int, 109, 1155, 10.1111/j.1464-410X.2011.10479.x
Ehdaie, 2011, Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma, J Urol, 186, 66, 10.1016/j.juro.2011.03.031
McLaughlin, 1992, Cigarette smoking and cancers of the renal pelvis and ureter, Cancer Res, 52, 254
Simsir, 2011, Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status, Int Urol Nephrol, 43, 1039, 10.1007/s11255-011-9915-z
Akdogan, 2006, Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma, J Urol, 176, 48, 10.1016/S0022-5347(06)00511-8
Zigeuner, 2006, Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location, BJU Int, 98, 1181, 10.1111/j.1464-410X.2006.06519.x
Park, 2009, The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival, J Urol, 182, 894, 10.1016/j.juro.2009.05.040
Ouzzane, 2011, Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy, Eur Urol, 60, 1258, 10.1016/j.eururo.2011.05.049
Kamihira, 2009, Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan, Eur Urol, 55, 1397, 10.1016/j.eururo.2009.03.003
Isbarn, 2009, Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma, J Urol, 182, 2177, 10.1016/j.juro.2009.07.035
Favaretto, 2010, The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center, Eur Urol, 58, 574, 10.1016/j.eururo.2010.07.003
Raman, 2010, Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy, Eur Urol, 57, 1072, 10.1016/j.eururo.2009.07.002
Brown, 2007, Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy, Urology, 70, 252, 10.1016/j.urology.2007.03.051
Guarnizo, 2000, Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach, J Urol, 163, 52, 10.1016/S0022-5347(05)67970-0
Brien, 2010, Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma, J Urol, 184, 69, 10.1016/j.juro.2010.03.030
Smith, 2011, Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management, Urology, 78, 82, 10.1016/j.urology.2011.02.038
Scolieri, 2000, Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma, Urology, 56, 930, 10.1016/S0090-4295(00)00800-1
Cho, 2007, Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma, Urology, 70, 662, 10.1016/j.urology.2007.06.1106
Ito, 2011, Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma, J Urol, 185, 1621, 10.1016/j.juro.2010.12.035
Ng, 2011, Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?, Urol Oncol, 29, 27, 10.1016/j.urolonc.2008.10.023
Inman, 2009, Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality, Cancer, 115, 2853, 10.1002/cncr.24339
Raman, 2011, Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?, Urol Oncol, 29, 716, 10.1016/j.urolonc.2009.11.007
Mullerad, 2004, Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma, J Urol, 172, 2177, 10.1097/01.ju.0000144505.40915.98
Novara, 2007, Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers, Cancer, 110, 1715, 10.1002/cncr.22970
Li, 2009, The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy, J Urol, 182, 451, 10.1016/j.juro.2009.04.026
Tran, 2008, Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance, J Urol, 179, 96, 10.1016/j.juro.2007.08.131
Boorjian, 2005, Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma, Urology, 66, 283, 10.1016/j.urology.2005.02.022
Sundi, 2012, Upper tract urothelial carcinoma: impact of time to surgery, Urol Oncol, 30, 266, 10.1016/j.urolonc.2010.04.002
Waldert, 2010, A delay in radical nephroureterectomy can lead to upstaging, BJU Int, 105, 812, 10.1111/j.1464-410X.2009.08821.x
Roupret, 2007, Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience, Urology, 69, 656, 10.1016/j.urology.2007.01.007
Capitanio, 2009, Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases, Eur Urol, 56, 1, 10.1016/j.eururo.2009.03.072
Favaretto, 2010, Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?, Eur Urol, 58, 645, 10.1016/j.eururo.2010.08.005
Walton, 2011, Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort, BJU Int, 108, 406, 10.1111/j.1464-410X.2010.09826.x
Simone, 2009, Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study, Eur Urol, 56, 520, 10.1016/j.eururo.2009.06.013
Aboussaly, 2010, Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma, Urology, 76, 895, 10.1016/j.urology.2010.04.020
Saika, 2004, Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis, Urology, 63, 848, 10.1016/j.urology.2003.12.003
Matin, 2005, Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control, J Urol, 173, 395, 10.1097/01.ju.0000148851.68215.93
Walton, 2009, Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma, J Urol, 181, 532, 10.1016/j.juro.2008.10.032
Lughezzani, 2010, Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study, Eur Urol, 57, 956, 10.1016/j.eururo.2009.12.001
Phe, 2011, Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy?, BJU Int, 108, 130, 10.1111/j.1464-410X.2010.09835.x
Brown, 2005, Hand-assisted laparoscopic nephroureterectomy: analysis of distal ureterectomy technique, margin status, and surgical outcomes, Urology, 66, 1192, 10.1016/j.urology.2005.06.086
Matin, 2005, Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status, BJU Int, 95, 68, 10.1111/j.1464-410X.2005.05203.x
Romero, 2007, Oncologic outcomes of extravesical stapling of distal ureter in laparoscopic nephroureterectomy, J Endourol, 21, 1025, 10.1089/end.2006.0306
Brausi, 2007, Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival, Eur Urol, 52, 1414, 10.1016/j.eururo.2007.04.070
Roscigno, 2009, Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy, J Urol, 181, 2482, 10.1016/j.juro.2009.02.021
Burger, 2011, No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study, World J Urol, 29, 465, 10.1007/s00345-011-0705-0
Kondo, 2007, Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract, J Urol, 178, 1212, 10.1016/j.juro.2007.05.158
Kondo, 2010, Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival, Int J Urol, 17, 848, 10.1111/j.1442-2042.2010.02610.x
Roscigno, 2009, Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer, Urology, 74, 1070, 10.1016/j.urology.2009.04.084
Roscigno, 2009, The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?, Eur Urol, 56, 512, 10.1016/j.eururo.2009.06.004
Roscigno, 2011, Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer, Eur Urol, 60, 776, 10.1016/j.eururo.2011.07.009
Bolenz, 2008, Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma, Urology, 72, 364, 10.1016/j.urology.2008.04.032
Brown, 2006, Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?, BJU Int, 98, 1176, 10.1111/j.1464-410X.2006.06524.x
Langner, 2006, pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract, Mod Pathol, 19, 272, 10.1038/modpathol.3800529
Li, 2008, Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients, Eur Urol, 54, 1127, 10.1016/j.eururo.2008.01.054
Margulis, 2009, Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration, Cancer, 115, 1224, 10.1002/cncr.24135
Rabbani, 2001, Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance, J Clin Oncol, 19, 94, 10.1200/JCO.2001.19.1.94
Lopez-Beltran, 2004, Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis, Eur Urol, 45, 257, 10.1016/j.eururo.2003.09.018
Sauter, 2004, Noninvasive urothelial neoplasias: WHO classification of noninvasive papillary urothelial tumors, 110
Pieras, 2010, Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma, BJU Int, 106, 1319, 10.1111/j.1464-410X.2010.09341.x
Wheat, 2012, Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy, Urol Oncol, 30, 252, 10.1016/j.urolonc.2010.01.001
Otto, 2011, Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients, World J Urol, 29, 487, 10.1007/s00345-011-0645-8
Youssef, 2011, Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma, Urology, 77, 861, 10.1016/j.urology.2010.09.032
Lughezzani, 2010, A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma, Urology, 75, 118, 10.1016/j.urology.2009.07.1296
Bolenz, 2009, Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density, BJU Int, 103, 302, 10.1111/j.1464-410X.2008.07988.x
Keeley, 1997, Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma, J Urol, 157, 33, 10.1016/S0022-5347(01)65273-X
Chromecki, 2012, The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy, Eur Urol, 61, 245, 10.1016/j.eururo.2011.09.017
Langner, 2006, Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract, Virchows Arch, 448, 604, 10.1007/s00428-006-0150-4
Remzi, 2009, Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients, BJU Int, 103, 307, 10.1111/j.1464-410X.2008.08003.x
Fritsche HM, Novara G, Burger M, et al. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol. In press. http://dx.doi.org/10.1016/j.urolonc.2010.07.010.
Simone, 2009, Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma, BJU Int, 103, 1052, 10.1111/j.1464-410X.2008.08134.x
Bolenz, 2009, Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis, BJU Int, 103, 1040, 10.1111/j.1464-410X.2008.08135.x
Kikuchi, 2005, Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract, J Urol, 174, 2120, 10.1097/01.ju.0000181801.22474.8b
Lin, 2008, The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0), J Urol, 180, 879, 10.1016/j.juro.2008.05.022
Kikuchi, 2009, Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma, J Clin Oncol, 27, 612, 10.1200/JCO.2008.17.2361
Novara, 2010, Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study, Eur Urol, 57, 1064, 10.1016/j.eururo.2009.12.029
Langner, 2006, Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract, J Urol, 176, 910, 10.1016/j.juro.2006.04.019
Lee, 2007, Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract, Jpn J Clin Oncol, 37, 49, 10.1093/jjco/hyl123
Zigeuner, 2010, Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract, Eur Urol, 57, 575, 10.1016/j.eururo.2009.11.035
Seitz, 2010, Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study, J Urol, 184, 1895, 10.1016/j.juro.2010.06.106
Lane, 2010, Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy, Cancer, 116, 2967, 10.1002/cncr.25043
Matin, 2010, Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma, Cancer, 116, 3127, 10.1002/cncr.25050
Bamias, 2004, Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group, J Clin Oncol, 22, 2150, 10.1200/JCO.2004.09.043
Kwak, 2006, Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract, Urology, 68, 53, 10.1016/j.urology.2006.01.053
Soga, 2008, Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma, Int J Urol, 15, 800, 10.1111/j.1442-2042.2008.02114.x
Hellenthal, 2009, Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration, J Urol, 182, 900, 10.1016/j.juro.2009.05.011
Vassilakopoulou, 2011, Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study, Cancer, 117, 5500, 10.1002/cncr.26172
O’Brien, 2011, Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial), Eur Urol, 60, 703, 10.1016/j.eururo.2011.05.064
Rey, 1997, Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter: relation to tumor proliferation and survival, Cancer, 79, 2178, 10.1002/(SICI)1097-0142(19970601)79:11<2178::AID-CNCR16>3.0.CO;2-T
Hashimoto, 2000, Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter, Int J Urol, 7, 457, 10.1046/j.1442-2042.2000.00230.x
Zigeuner, 2004, Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma, Urology, 63, 1079, 10.1016/j.urology.2004.01.009
Jeon HG, Jeong IG, Bae J, et al. Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma. Urology 2010;76:513 e7–12.
Joung, 2008, Identification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumors, Urol Int, 81, 306, 10.1159/000151409
Leibl, 2008, EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology, APMIS, 116, 27, 10.1111/j.1600-0463.2008.00859.x
Ohtsuka, 2006, Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract, BJU Int, 97, 1322, 10.1111/j.1464-410X.2006.06158.x
Kosaka, 2010, Expression of Snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion, Clin Cancer Res, 16, 5814, 10.1158/1078-0432.CCR-10-0230
Nakanishi, 2002, Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract, Virchows Arch, 441, 559, 10.1007/s00428-002-0712-z
Jeong, 2009, Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract, Hum Pathol, 40, 668, 10.1016/j.humpath.2008.10.010
Nakanishi, 1999, Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract, Cancer, 86, 2109, 10.1002/(SICI)1097-0142(19991115)86:10<2109::AID-CNCR32>3.0.CO;2-6
Nakanishi, 2005, Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract, Clin Cancer Res, 11, 2583, 10.1158/1078-0432.CCR-04-1685
Ke, 2008, Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract, Int J Urol, 15, 200, 10.1111/j.1442-2042.2007.01978.x
Inoue, 2002, The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter, Clin Cancer Res, 8, 1863
Miyata, 2004, Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival, Urology, 63, 602, 10.1016/j.urology.2003.09.035
Nakanishi, 1997, E-cadherin expression in upper-urinary-tract carcinoma, Int J Cancer, 74, 446, 10.1002/(SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7
Fromont, 2005, Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma, Eur Urol, 48, 764, 10.1016/j.eururo.2005.07.005
Izquierdo, 2009, Adhesion molecules alpha, beta and gamma-catenin as prognostic factors of tumour progression in upper urinary tract urothelial tumours: the role of AKT-P/GSK-3beta/beta-catenin pathway, BJU Int, 104, 100, 10.1111/j.1464-410X.2008.08292.x
Wu, 2010, Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract, Br J Cancer, 103, 852, 10.1038/sj.bjc.6605835
Winkler, 2007, CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression, Virchows Arch, 450, 59, 10.1007/s00428-006-0316-0
Saito, 2007, The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically, BJU Int, 100, 269, 10.1111/j.1464-410X.2007.06934.x
Lehmann, 2007, Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival, Eur Urol, 51, 1281, 10.1016/j.eururo.2006.11.021
Suyama, 2011, Prognostic significance of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma, Int J Urol, 18, 43, 10.1111/j.1442-2042.2010.02671.x
Roupret, 2004, Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma, J Med Genet, 41, e91, 10.1136/jmg.2003.017871
Roupret, 2005, Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma, Urology, 65, 1233, 10.1016/j.urology.2005.01.019
Catto, 2005, Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma, J Clin Oncol, 23, 2903, 10.1200/JCO.2005.03.163
van Oers, 2009, FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours, Eur Urol, 55, 650, 10.1016/j.eururo.2008.06.013
Skolarikos, 2003, Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment, Urology, 61, 1146, 10.1016/S0090-4295(03)00026-8
Williams, 2008, Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma, J Endourol, 22, 71, 10.1089/end.2007.9853
Chen, 2008, Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma?, J Endourol, 22, 1371, 10.1089/end.2008.0096
Marín-Aguilera, 2007, Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma, Eur Urol, 51, 409, 10.1016/j.eururo.2006.08.045
Luo, 2009, Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma, Cancer Genet Cytogenet, 189, 93, 10.1016/j.cancergencyto.2008.10.015
Mian, 2010, Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours, Eur Urol, 58, 288, 10.1016/j.eururo.2010.04.026
Xu, 2011, Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients, Urology, 77, 636, 10.1016/j.urology.2010.07.498
Johannes, 2010, Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance, J Urol, 184, 879, 10.1016/j.juro.2010.05.023
Fernandez MI, Parikh S, Grossman HB, et al. The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer. Urol Oncol. In press. http://dx.doi.org/10.1016/j.urolonc.2010.08.006
Margulis, 2010, Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract, J Urol, 184, 453, 10.1016/j.juro.2010.03.142
Favaretto, 2012, Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma, BJU Int, 109, 77, 10.1111/j.1464-410X.2011.10288.x
Jeldres, 2010, Highly predictive survival nomogram after upper urinary tract urothelial carcinoma, Cancer, 116, 3774, 10.1002/cncr.25122